AKT1 and hepatocellular carcinoma: The enrichment study identified significant enrichment in pathways, including Pathways in Cancer, the PI3K-Akt signaling pathway, the mTOR signaling pathway, the TGF-β signaling pathway, and the specific HCC pathway.